CTI Clinical Trial and Consulting Services

General information
CTI Clinical Trial and Consulting Services
Schillerstrasse 1/15
89077 Ulm, Baden-Württemberg
Germany

Contact person: Christiane Alexander, Business Development & Client Management
Company main phone: +49 (731) 4000840
Website:  https://www.ctifacts.com
Year founded:1999
Source of foundation:Subsidiary
Name of foundation source:CTI Clinical Trial and Consulting Services, USA
No. of employees: Worldwide:  1300
Corporate description / mission:
CTI Clinical Trial and Consulting Services provides drug development services. CTI is conducting clinical trials with life-changing therapies in chronically and critically ill patient populations. The company offers clinical trials, drug and device development, medical education, healthcare communication, early-phase development, and health outcomes research. 
State of ownership: Private / independent
Headquarters: HQ: No
Remarks on ownership / listings
CTI is privately owned since our inception.
Categorization
Sector:
  • Professional Services and Consulting
Subsector:
  • Drug development consulting
  • Regulatory Affairs
  • Translation services
Primary therapeutic areas:
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the ear / otology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Mental and behavioural disorders / psychiatry /psychology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Respiratory / pulmonology
Business model:
  • Research on contract basis
  • Service company
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
  • Small medtech
Distribution:
  • Direct (own sales force)
Summary Products / Services / Technologies
Description of products:
Regulatory strategic consulting including drug modeling
Clinical trial services PhI-IV,
Central lab services (safety, PK/PD, bioanalytics)
CRC - phase I unit,
RWE services, market access.
© 2025 Biotechgate by Venture Valuation
X